The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction

University of British Columbia

Status and phase

Unknown

Phase 1

Conditions

Pain, Postoperative

Treatments

Procedure: Administration of a femoral nerve block (bupivacaine HCL)

Study type

Interventional

Funder types

Other

Identifiers

NCT00175630

W05-0024

H05-70078

Details and patient eligibility

About

This study evaluates the effect of a femoral nerve block on opioid requirements following anterior cruciate ligament (ACL) reconstruction. This is a double blind, prospective randomized controlled trial.

Enrollment

30 patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Schedule for primary elective anterior cruciate ligament reconstruction
Tolerance to bupivacaine
Tolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
Informed consent

Exclusion criteria

Patients who received a femoral nerve block more than 1 hour prior to surgery
Complex associated injuries or pre-existing conditions that will delay time to ambulation
Children with tibial avulsion fractures
Allergic and/or sensitive to bupivacaine and/or NSAIDs
30% over ideal body weight
Acute ACL reconstruction (done less than 2 weeks after injury)
Pre-existing femoral nerve injury
Psychiatric patients on psychotropic agents
History of drug or alcohol dependence or recreational drug use
Refusal to provide informed consent